Total Valuation
PharmaCielo has a market cap or net worth of $7.24M. The enterprise value is $31.59M.
Market Cap$7.24M
Enterprise Value$31.59M
Share Statistics
PharmaCielo has 221,005,070 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding221,005,070
Owned by Insiders14.28%
Owned by Institutions0.14%
Financial Efficiency
PharmaCielo’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is -116.13%.
Return on Equity (ROE)0.30
Return on Assets (ROA)-0.53
Return on Invested Capital (ROIC)-116.13%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee9.74K
Profits Per Employee-16.99K
Employee Count268
Asset Turnover0.30
Inventory Turnover1.08
Valuation Ratios
The current PE Ratio of PharmaCielo is ―. PharmaCielo’s PEG ratio is -0.01.
PE Ratio―
PS Ratio3.24
PB Ratio-0.55
Price to FCF-8.30
Price to Operating Cash Flow-1.49
PEG Ratio-0.01
Income Statement
In the last 12 months, PharmaCielo had revenue of 2.61M and earned -4.55M in profits. Earnings per share was -0.03.
Revenue2.61M
Gross Profit756.40K
Operating Income-3.82M
Pretax Income-4.55M
Net Income-4.55M
EBITDA-1.00M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -6.96M and capital expenditures 8.00, giving a free cash flow of -6.96M billion.
Operating Cash Flow-6.96M
Free Cash Flow-6.96M
Free Cash Flow per Share-0.03
Dividends & Yields
PharmaCielo pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-2.01
52-Week Price Change19.35%
50-Day Moving Average0.04
200-Day Moving Average0.05
Relative Strength Index (RSI)51.11
Average Volume (3m)17.89K
Important Dates
PharmaCielo upcoming earnings date is May 3, 2027, Before Open (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateMay 3, 2027
Ex-Dividend Date―
Financial Position
PharmaCielo as a current ratio of 0.15, with Debt / Equity ratio of -170.28%
Current Ratio0.15
Quick Ratio0.08
Debt to Market Cap2.20
Net Debt to EBITDA-18.31
Interest Coverage Ratio-1.38
Taxes
In the past 12 months, PharmaCielo has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PharmaCielo EV to EBITDA ratio is -26.75, with an EV/FCF ratio of -26.31.
EV to Sales10.27
EV to EBITDA-26.75
EV to Free Cash Flow-26.31
EV to Operating Cash Flow-26.31
Balance Sheet
PharmaCielo has $77.50K in cash and marketable securities with $18.21M in debt, giving a net cash position of -$18.14M billion.
Cash & Marketable Securities$77.50K
Total Debt$18.21M
Net Cash-$18.14M
Net Cash Per Share-$0.08
Tangible Book Value Per Share-$0.08
Margins
Gross margin is 37.20%, with operating margin of -146.43%, and net profit margin of -174.39%.
Gross Margin37.20%
Operating Margin-146.43%
Pretax Margin-174.39%
Net Profit Margin-174.39%
EBITDA Margin-38.40%
EBIT Margin-76.61%
Analyst Forecast
The average price target for PharmaCielo is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast1.65%
EPS Growth Forecast57.28%